Peroxynitrite flux-mediated LDL oxidation is inhibited by manganese porphyrins in the presence of uric acid

We have studied the role of three Mn(III)porphyrins differing in charge, alkyl substituent length and reactivity, on LDL exposed to low fluxes of peroxynitrite (PN) in the presence of uric acid. Mn(III)porphyrins (5 μM, MnTE-2-PyP5+, MnTnOct-2-PyP5+, and MnTCPP3−) plus uric acid (300 μM) inhibited cholesteryl ester hydroperoxide formation, changes in REM as well as spared α- and γ-tocopherol. MnTnOct-2-PyP5+, the more lipophilic compound, was the most effective in protecting LDL lipids, while MnTCPP3− exerted the lesser protection. Mn(III)porphyrins react fast with PN (not, vert, similar105−107 M−1 s−1) to yield a O=Mn(IV) complex. The stoichiometry of uric acid consumption was not, vert, similar1.7 moles per mol of PN, in agreement with reactions with both the O=Mn(IV) complex and nitrogen dioxide. A shift from an anti- to a pro-oxidant action of the Mn(III)porphyrin was observed after uric acid was significantly consumed, supporting competition reactions between LDL targets and uric acid for the O=Mn(IV) complex. Overall, the data is consistent with the catalytic reduction of PN in a cycle that involves a one electron oxidation of Mn(III) to Mn(IV) by PN followed by the reduction back to Mn(III) by uric acid. These antioxidant effects should predominate under in vivo conditions having plasma uric acid concentration range between 150 and 500 μM.